Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Pefloxacin Stories

2014-02-20 23:23:30

Drug Allegedly Linked to Serious Muscle Problems and Nerve Damage Dallas, TX (PRWEB) February 20, 2014 The national law firm of Baron and Budd is now representing clients filing lawsuits against the maker of Cipro, an antibiotic that has been allegedly linked to nerve damage and peripheral neuropathy. This is a muscle condition that can lead to several problems, including difficulty walking, significant pain and arm and leg numbness. Cipro, the brand name for the drug ciprofloxacin, is...

2014-02-05 12:28:03

Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed enrollment in three phase 3 safety studies of ETI-204, an anti-toxin in development for the treatment of inhalational anthrax. Elusys also announced it has completed enrollment in an additional study to evaluate the tolerability...

2013-11-27 15:08:04

In contrast to findings of a recent study, researchers in Denmark did not find an association between use of a class of antibiotics known as fluoroquinolones (such as ciprofloxacin) and an increased risk of retinal detachment, according to a study appearing in the November 27 issue of JAMA. Retinal detachment (a separation of the retina from its connection at the back of the eye) is an acute eye disorder that may lead to loss of vision despite prompt surgical intervention. A recent study...

2013-10-11 23:25:47

The United States Food and Drug Administration (FDA) has recently issued a Drug Safety Announcement and approved a Black Box Warning, one of the harshest warnings, for Pfizer’s antibiotic intravenous (IV) drug Tygacil®. In particular, the FDA warns prescribing doctors and consumers that use of the IV drug Tygacil® is associated with an increased risk of death in comparison to other antibiotic drugs and that the IV antibiotic Tygacil® should only be used in situations where...

2013-08-29 23:30:41

Media health report cites problems with prescribing of antibiotics such as Zithromax by physicians. Resource4thePeople announces it will continue to provide free legal consultations about rights to legal compensation over allegations of dangerous side effects from the use of Zithromax and Zmax SR. San Diego, CA (PRWEB) August 29, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html Resource4thePeople announced today its latest update for consumers keeping abreast...

2013-05-16 12:30:20

SARASOTA, Fla., May 16, 2013 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies have provided new evidence that its novel class of antimicrobials, named bisphosphocins, function through a completely unique mechanism of action involving bacterial membrane depolarization, resulting in rapid direct bacterial killing. These studies expand on previously published experiments demonstrating Nu-3...

2013-04-30 08:27:44

WASHINGTON, April 30, 2013 /PRNewswire-USNewswire/ -- The National Turkey Federation (NTF) strongly disputes the misleading findings of a Consumer Reports article about ground turkey, which makes a number of alarming claims based on an extremely small sampling of ground turkey products. "Consumer Reports had the opportunity to foster a serious, thoughtful discussion about food safety, but instead it chose to sensationalize findings and mislead people," said NTF President Joel Brandenberger....

Z-Pack Antibiotic Warning From The FDA
2013-03-13 05:35:24

redOrbit Staff & Wire Reports - Your Universe Online A commonly-prescribed antibiotic could trigger potentially fatal irregular heart rhythms in some patients, officials from the US Food and Drug Administration (FDA) warned on Tuesday. Azithromycin, which is commonly sold as Zithromax or Zmax and is sometimes referred to as a “Z-Pack,” could cause the condition in patients who have an elevated risk of developing cardiovascular problems, reports Deborah Kotz of the Boston...

2012-09-06 18:22:45

MENLO PARK, Calif., Sept. 7, 2012 /PRNewswire/ -- Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12. The data describe the in vitro and in vivo activity of KPI-10 against a wide range of important gram-negative and...

2012-06-21 02:05:05

A potential new approach for treating urinary tract infections (UTIs) – which affect millions of people annually – without traditional antibiotics is being reported in ACS' Journal of Medicinal Chemistry. It involves so-called FimH antagonists, which are non-antibiotic compounds and would not contribute to the growing problem of antibiotic resistance bacteria. Beat Ernst and colleagues explain that antibiotics are the mainstay treatment for UTIs. Bacteria, however, are...